Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| MVZ Medizinische Genetik Mainz | RCV004555732 | SCV005044685 | likely pathogenic | X-linked Alport syndrome | 2024-03-07 | criteria provided, single submitter | clinical testing | ACMG Criteria: PP3_STR,PM5,PM1_SUP,PM2_SUP,PP4 |
| Victorian Clinical Genetics Services, |
RCV004555732 | SCV005086595 | pathogenic | X-linked Alport syndrome | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with X-linked Alport syndrome 1 (MIM#301050). Dominant negative is caused mostly by glycine substitutions that affect the conformation of the protein, and loss of function can be caused by either protein truncating or missense variants (PMID: 24046192, 12028435). (I) 0110 - This gene is associated with X-linked dominant disease. Males are typically more severely affected than females (PMID: 19965530). (I) 0115 - Variants in this gene are known to have variable expressivity. There is intrafamilial variability among affected carrier females, possibly due to variable X-inactivation (PMID: 14514738). (I) 0200 - Variant is predicted to result in a missense amino acid change from cysteine to arginine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0601 - Variant is located in the well-established functional C4 domain (DECIPHER, PMID: 36721056). (SP) 0702 - Other variants comparable to the one identified in this case have strong previous evidence for pathogenicity. Other amino acid changes at the same position, p.(Cys1638Ser) , p.(Cys1638Tyr) and (Cys1638Trp), have been reported as pathogenic/likely pathogenic in individuals with Alport syndrome (ClinVar, PMID: 24033287, PMID: 26809805, PMID: 17277342). (SP) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant was reported as pathogenic in PMID: 35789182, citing LOVD as the source. However, the variant is not currently listed in LOVD and therefore, there is uncertainty regarding this classification. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |